Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator
The new recommendation will significantly expand access to Wegovy on the England's NHS.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0


Comments (0)